Key result
Routine use of rotavirus vaccines in national programs has reduced all-cause diarrhea hospitalizations by 17%-55%, rotavirus hospitalizations by 49%-92%, and all-cause diarrhea deaths by 22%-50%.
Why the study?
Do rotavirus vaccines reduce diarrhea, hospitalizations, and deaths in children?
Do rotavirus vaccines reduce diarrhea, hospitalizations, and deaths in children?
Routine use of rotavirus vaccines significantly reduces diarrhea-related hospitalizations and deaths in children, with a highly favorable risk-benefit profile.
Answers are grounded in this paper and cite their sources.
Supports real-world rotavirus vaccine impact on pediatric diarrhea; leaves open need for controlled trials to confirm durability and equity.
Vaccines are now available to combat rotavirus, the most common cause of severe diarrhea among children worldwide. We review clinical trial data for available rotavirus vaccines and summarize postlicensure data on effectiveness, impact, and safety from countries routinely using these vaccines in national programs. In these countries, rotavirus vaccines have reduced all-cause diarrhea and rotavirus hospitalizations by 17%-55% and 49%-92%, respectively, and all-cause diarrhea deaths by 22%-50% in some settings. Indirect protection of children who are age-ineligible for rotavirus vaccine has also been observed in some high and upper middle income countries. Experience with routine use of rotavirus vaccines in lower middle income countries has been limited to date, but vaccine introductions in such countries have been increasing in recent years. The risk-benefit analysis of rotavirus vaccines is extremely favorable but other strategies to improve the effectiveness of the vaccine, particularly in lower middle income settings, should be considered.
No takes yet. Share an insight, caveat, or question.
Tate et al. (2014) conducted a review in Severe diarrhea caused by rotavirus. Rotavirus vaccines was evaluated on All-cause diarrhea hospitalizations, rotavirus hospitalizations, and all-cause diarrhea deaths. Routine use of rotavirus vaccines in national programs has reduced all-cause diarrhea hospitalizations by 17%-55%, rotavirus hospitalizations by 49%-92%, and all-cause diarrhea deaths by 22%-50%.
Synapse has enriched 10 related papers. Consider them for comparative context: